Literature DB >> 22886340

Risk factors for pseudogout in the general population.

Young Hee Rho1, Yanyan Zhu, Yuqing Zhang, Anthony M Reginato, Hyon K Choi.   

Abstract

Objective. To evaluate the association between the purported risk factors for chondrocalcinosis and gout and the risk of pseudogout in the general population. Methods. We conducted a case-control study nested within a UK general practice database (The Health Improvement Network) by identifying incident cases of pseudogout between 1986 and 2007 and up to 10 control subjects matched to each case, based on age, sex and follow-up time. We evaluated the purported risk factors for chondrocalcinosis (i.e. OA, RA, hyperparathyroidism and diuretics) and established risk factors for gout (as comparison exposures) using conditional logistic regression analysis. Results. We identified 795 cases of pseudogout and 7770 matched control subjects. The risk of pseudogout was associated with hyperparathyroidism [odds ratio (OR) 4.87; 95% CI 2.10, 11.3], OA (OR 2.91; 95% CI 2.48, 3.43) and loop diuretic use (OR 1.35; 95% CI 1.09, 1.67). RA, thiazide diuretic use, BMI and other gout risk factors were not associated with the risk of pseudogout, except for chronic renal failure (OR 2.29; 95% CI 1.30, 4.01). Conclusion. This general population study based on physician-recorded pseudogout suggests that most of the previously observed associations with chondrocalcinosis are replicable with the risk of pseudogout, but there are notable differences, such as thiazide diuretics, RA and chronic renal failure, highlighting the need to study the clinical outcome, pseudogout. Avoiding loop diuretics may help individuals with recurrent pseudogout.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886340      PMCID: PMC3475980          DOI: 10.1093/rheumatology/kes204

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

Review 1.  Divalent cation transport by the distal nephron: insights from Bartter's and Gitelman's syndromes.

Authors:  D H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2000-10

2.  Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy.

Authors:  W Zhang; R Neame; S Doherty; M Doherty
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  ATP release by mechanically loaded porcine chondrons in pellet culture.

Authors:  R D Graff; E R Lazarowski; A J Banes; G M Lee
Journal:  Arthritis Rheum       Date:  2000-07

4.  European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Authors:  W Zhang; M Doherty; T Bardin; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; E Pascual
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

5.  Acute pseudogout in chronic renal failure.

Authors:  M H Ellman; N L Brown; C A Katzenberg
Journal:  Arch Intern Med       Date:  1979-07

Review 6.  An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Pascal Richette; Thomas Bardin; Michael Doherty
Journal:  Rheumatology (Oxford)       Date:  2009-04-27       Impact factor: 7.580

7.  UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.

Authors:  R L Neame; A J Carr; K Muir; M Doherty
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

8.  The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

Authors:  Ian H De Boer; Irina Gorodetskaya; Belinda Young; Chi-Yuan Hsu; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

9.  Acute pseudogout arthritis in a patient with chronic renal failure: a case report.

Authors:  N Yildiz; F Ardic; O Ercidogan; S Coban
Journal:  Clin Nephrol       Date:  2008-11       Impact factor: 0.975

10.  Contemporary epidemiology of gout in the UK general population.

Authors:  Lucía Cea Soriano; Dietrich Rothenbacher; Hyon K Choi; Luis A García Rodríguez
Journal:  Arthritis Res Ther       Date:  2011-03-03       Impact factor: 5.156

View more
  20 in total

Review 1.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

2.  Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.

Authors:  Crystal Kleiber Balderrama; Ann K Rosenthal; Daniel Lans; Jasvinder A Singh; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

Review 3.  Issues in CPPD Nomenclature and Classification.

Authors:  Sara K Tedeschi
Journal:  Curr Rheumatol Rep       Date:  2019-07-25       Impact factor: 4.592

4.  Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease.

Authors:  Sara K Tedeschi; Daniel H Solomon; Katherine P Liao
Journal:  Rheumatol Int       Date:  2018-04-17       Impact factor: 2.631

5.  Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study.

Authors:  Christie M Bartels; Jasvinder A Singh; Konstantinos Parperis; Karri Huber; Ann K Rosenthal
Journal:  J Clin Rheumatol       Date:  2015-06       Impact factor: 3.517

Review 6.  Review: Outcome measures in calcium pyrophosphate deposition.

Authors:  Ken Cai; Sara K Tedeschi
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-11-17       Impact factor: 4.098

7.  [Renal diseases in rheumatology].

Authors:  M Janneck; J Velden; C Iking-Konert
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

8.  Concurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A case collection and review of the literature.

Authors:  Viktoriya Sabchyshyn; Irina Konon; Lawrence M Ryan; Ann K Rosenthal
Journal:  Semin Arthritis Rheum       Date:  2017-12-02       Impact factor: 5.532

9.  Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence.

Authors:  Katherine A Yates; Kazuki Yoshida; Chang Xu; Houchen Lyu; Vibeke Norvang; Daniel H Solomon; Sara K Tedeschi
Journal:  J Rheumatol       Date:  2019-11-01       Impact factor: 4.666

10.  Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data.

Authors:  Sara K Tedeschi; Tianrun Cai; Zeling He; Yuri Ahuja; Chuan Hong; Katherine A Yates; Kumar Dahal; Chang Xu; Houchen Lyu; Kazuki Yoshida; Daniel H Solomon; Tianxi Cai; Katherine P Liao
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.